540596 Stock Overview
Provides domestic branded formulations for chronic and sub-chronic therapies in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Eris Lifesciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,365.95 |
| 52 Week High | ₹1,521.05 |
| 52 Week Low | ₹810.10 |
| Beta | 0.33 |
| 11 Month Change | 7.05% |
| 3 Month Change | 8.37% |
| 1 Year Change | 44.51% |
| 33 Year Change | 83.34% |
| 5 Year Change | 206.82% |
| Change since IPO | 127.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540596 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.9% | -0.5% | -1.2% |
| 1Y | 44.5% | 41.6% | 25.5% |
Return vs Industry: 540596 exceeded the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 540596 exceeded the Indian Market which returned 27.3% over the past year.
Price Volatility
| 540596 volatility | |
|---|---|
| 540596 Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 540596 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540596's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 3,620 | Amit Bakshi | www.eris.co.in |
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions.
Eris Lifesciences Limited Fundamentals Summary
| 540596 fundamental statistics | |
|---|---|
| Market cap | ₹186.04b |
| Earnings (TTM) | ₹3.48b |
| Revenue (TTM) | ₹24.85b |
53.4x
P/E Ratio7.5x
P/S RatioIs 540596 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540596 income statement (TTM) | |
|---|---|
| Revenue | ₹24.85b |
| Cost of Revenue | ₹5.90b |
| Gross Profit | ₹18.95b |
| Other Expenses | ₹15.47b |
| Earnings | ₹3.48b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 25.60 |
| Gross Margin | 76.25% |
| Net Profit Margin | 14.02% |
| Debt/Equity Ratio | 84.8% |
How did 540596 perform over the long term?
See historical performance and comparison